The Breakthrough Leadership Team has dedicated their careers to the investment, construction and operations of best-in-class life science real estate.
Breakthrough Properties is backed by a joint venture between Tishman Speyer and Bellco Capital.
Rob Speyer
Tishman Speyer
President and Chief Executive Officer
President and Chief Executive Officer
Arie Belldegrun, M.D.
Bellco Capital
Chairman
Chairman
Rebecka Belldegrun, M.D.
Bellco Capital
Founder and Chief Executive Officer
Founder and Chief Executive Officer
Paul Galiano
Tishman Speyer
Senior Managing Director, Co-Head of U.S. Acquisitions
Senior Managing Director, Co-Head of U.S. Acquisitions
Joseph Doran
Tishman Speyer
Senior Managing Director, Chief Financial Officer
Senior Managing Director, Chief Financial Officer
Joshua Kazam
Two River Group
Co-Founder and Partner
Co-Founder and Partner
Michael Benner
Tishman Speyer
Senior Managing Director, General Counsel
Senior Managing Director, General Counsel
Josh Bradley
Bellco Capital
Chief Investment Officer
Chief Investment Officer
Our world-renowned Scientific Advisory Board (“SAB”) of leading scientists, entrepreneurs, CEOs and venture capital investors bring their decades of experience to our unique platform for the benefit of our client-tenants.
Arie Belldegrun, M.D.
Executive Chairman and Co-Founder of Allogene, Chairman of Bellco Capital, Two River Group, UroGen Pharma and Kronos Bio
Franz Humer, PhD
Chairman of Humer Foundation, Former Chairman and CEO of Roche Holding
Liz Barrett
CEO of UroGen Pharma, Former CEO of Oncology at Novartis
Owen N. Witte, M.D.
UCLA Professor of Microbiology, Immunology, and Molecular Genetics & President’s Chair of Development Immunology
David Chang, M.D., PhD
Co-Founder and CEO of Allogene Therapeutics, Former Chief Medical Officer of Kite Pharma
Helen S. Kim
Senior Managing Director at Vida Ventures, Former Partner at The Column Group and Executive Vice President of Business Development at Kite Pharma
Ben Belldegrun
Co-Founder and Managing Partner, Aliment Capital
Amy Schulman
Managing Partner at Polaris Partners, Former general counsel at Pfizer and President, Pfizer Consumer Healthcare
Jakob Loven, PhD
Managing Partner at Nextech Invest; co-founder Relay Therapeutics (NASDAQ: RLAY) and Syros Pharmaceuticals (NASDAQ: SYRS)